| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| SARIN RAVI YANG | 4.7% | $11,959,434 | 4,109,771 | Ravi Sarin | 26 Mar 2025 |
As of 31 Dec 2025, 115 institutional investors reported holding 38,475,289 shares of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI). This represents 44% of the company’s total 87,441,936 outstanding shares.
The largest institutional shareholders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) together control 39% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 5.4% | 4,748,635 | +4.5% | 0% | $16,905,141 |
| BlackRock, Inc. | 4.5% | 3,905,333 | +14% | 0% | $13,902,986 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.8% | 3,360,052 | 0% | 0.15% | $11,961,785 |
| CenterBook Partners LP | 3.5% | 3,029,312 | +12% | 0.53% | $10,784,351 |
| Kanen Wealth Management LLC | 3.4% | 2,976,144 | +62% | 3.3% | $10,712,000 |
| Balyasny Asset Management L.P. | 2.9% | 2,518,437 | +0% | 0.02% | $8,965,636 |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 2.8% | 2,459,809 | +1104% | 6.7% | $8,756,920 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 1,570,454 | +12% | 0% | $5,592,185 |
| WEXFORD CAPITAL LP | 1.8% | 1,533,456 | -2.4% | 1.4% | $5,459,100 |
| STATE STREET CORP | 1.5% | 1,351,624 | +20% | 0% | $4,811,781 |
| JANE STREET GROUP, LLC | 0.92% | 803,315 | +543% | 0% | $2,859,802 |
| RENAISSANCE TECHNOLOGIES LLC | 0.83% | 721,900 | -3.8% | 0% | $2,569,964 |
| BRC Group Holdings, Inc. | 0.76% | 663,376 | -18% | 1% | $2,361,619 |
| GOLDMAN SACHS GROUP INC | 0.65% | 570,424 | -16% | 0% | $2,030,709 |
| NORTHERN TRUST CORP | 0.57% | 499,244 | +7.4% | 0% | $1,777,308 |
| Massar Capital Management, LP | 0.46% | 400,000 | 0% | 0.28% | $1,424,000 |
| JPMORGAN CHASE & CO | 0.44% | 386,778 | +1483% | 0% | $1,376,930 |
| FourWorld Capital Management LLC | 0.44% | 382,700 | +6.9% | 1.3% | $1,362,412 |
| GatePass Capital, LLC | 0.41% | 360,000 | 0.66% | $1,281,600 | |
| FreeGulliver LLC | 0.41% | 355,672 | +69% | 0.57% | $1,266,192 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.34% | 295,150 | 0% | $1,050,734 | |
| UBS Group AG | 0.33% | 287,686 | -73% | 0% | $1,024,162 |
| LPL Financial LLC | 0.31% | 270,885 | +1.5% | 0% | $964,351 |
| TWO SIGMA INVESTMENTS, LP | 0.3% | 262,050 | -6.1% | 0% | $932,898 |
| Maven Securities LTD | 0.29% | 251,128 | +151% | 0.11% | $894,016 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 38,475,289 | $137,091,418 | +$13,634,767 | $3.56 | 115 |
| 2025 Q3 | 34,670,910 | $120,993,806 | +$10,399,257 | $3.49 | 107 |
| 2025 Q2 | 31,474,503 | $64,523,702 | +$31,211,552 | $2.05 | 78 |
| 2025 Q1 | 16,901,932 | $19,267,414 | +$2,727,938 | $1.14 | 42 |
| 2024 Q4 | 14,712,600 | $4,608,917 | -$2,191,797 | $0.31 | 30 |
| 2024 Q3 | 20,589,694 | $6,982,762 | +$385,704 | $0.33 | 34 |
| 2024 Q2 | 18,701,866 | $8,832,828 | -$155,334 | $0.46 | 38 |
| 2024 Q1 | 17,222,037 | $27,535,675 | -$2,492,260 | $1.58 | 44 |
| 2023 Q4 | 18,436,129 | $37,608,749 | +$6,554,810 | $2.04 | 44 |
| 2023 Q3 | 15,107,160 | $21,169,015 | +$1,157,191 | $1.40 | 36 |
| 2023 Q2 | 13,916,345 | $7,656,692 | -$4,490,020 | $0.55 | 37 |
| 2023 Q1 | 21,905,923 | $14,849,314 | -$1,309,674 | $0.68 | 37 |
| 2022 Q4 | 23,473,725 | $38,730,078 | -$1,269,944 | $1.65 | 37 |
| 2022 Q3 | 23,327,364 | $108,006,612 | +$6,672,135 | $4.63 | 39 |
| 2022 Q2 | 21,874,386 | $110,684,000 | +$2,844,383 | $5.06 | 33 |
| 2022 Q1 | 17,791,143 | $126,852,000 | -$752,294 | $7.13 | 27 |
| 2021 Q4 | 21,118,138 | $199,883,000 | +$185,679,000 | $9.75 | 21 |
| 2021 Q3 | 252,439 | $2,504,000 | +$2,504,000 | $9.92 | 1 |